“Bimekizumab long-term efficacy in patients with plaque psoriasis from BE BRIGHT: Improvements in mean absolute clinical outcome scores over 4 years” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s645. doi:10.25251/mextwf19.